• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梦魇与大麻素。

Nightmares and the Cannabinoids.

机构信息

Department of Psychiatry, University of Toronto, Baycrest Hospital, Permanent Address: 19 Tumbleweed Road, Toronto, Ontario M2J 2N2, Canada.

出版信息

Curr Neuropharmacol. 2020;18(8):754-768. doi: 10.2174/1570159X18666200114142321.

DOI:10.2174/1570159X18666200114142321
PMID:31934840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536831/
Abstract

The cannabinoids, Δ9 tetrahydrocannabinol and its analogue, nabilone, have been found to reliably attenuate the intensity and frequency of post-traumatic nightmares. This essay examines how a traumatic event is captured in the mind, after just a single exposure, and repeatedly replicated during the nights that follow. The adaptive neurophysiological, endocrine and inflammatory changes that are triggered by the trauma and that alter personality and behavior are surveyed. These adaptive changes, once established, can be difficult to reverse. But cannabinoids, uniquely, have been shown to interfere with all of these post-traumatic somatic adaptations. While cannabinoids can suppress nightmares and other symptoms of post-traumatic stress disorder, they are not a cure. There may be no cure. The cannabinoids may best be employed, alone, but more likely in conjunction with other agents, in the immediate aftermath of a trauma to mitigate or even abort the metabolic changes which are set in motion by the trauma and which may permanently alter the reactivity of the nervous system. Steps in this direction have already been taken.

摘要

大麻素,Δ9 四氢大麻酚及其类似物纳布隆,已被发现能可靠地减轻创伤后噩梦的强度和频率。本文探讨了创伤事件是如何在单次暴露后被大脑捕捉,并在随后的夜晚反复重现的。文中还调查了创伤引发的适应性神经生理、内分泌和炎症变化,这些变化改变了个性和行为。这些适应性变化一旦确立,就很难逆转。但是大麻素,独一无二,已被证明可以干扰所有这些创伤后的躯体适应。虽然大麻素可以抑制噩梦和创伤后应激障碍的其他症状,但它们并不是一种治愈方法。可能没有治愈方法。大麻素可能最好单独使用,但更可能与其他药物联合使用,在创伤发生后的立即治疗中,减轻甚至阻止由创伤引发的代谢变化,这些变化可能会永久改变神经系统的反应性。已经朝着这个方向迈出了一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630e/7536831/f7f3f009a2c4/CN-18-754_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630e/7536831/f7f3f009a2c4/CN-18-754_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630e/7536831/f7f3f009a2c4/CN-18-754_F1.jpg

相似文献

1
Nightmares and the Cannabinoids.梦魇与大麻素。
Curr Neuropharmacol. 2020;18(8):754-768. doi: 10.2174/1570159X18666200114142321.
2
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).一种合成大麻素在创伤后应激障碍(PTSD)难治性噩梦治疗中的应用。
CNS Neurosci Ther. 2009 Winter;15(1):84-8. doi: 10.1111/j.1755-5949.2008.00071.x.
3
Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.在惩教人群中使用合成大麻素治疗创伤后应激障碍相关的失眠和噩梦、慢性疼痛、减少伤害及其他适应症:一项回顾性评估。
J Clin Psychopharmacol. 2014 Oct;34(5):559-64. doi: 10.1097/JCP.0000000000000180.
4
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.大麻素在创伤后应激障碍患者治疗中的应用。
J Basic Clin Physiol Pharmacol. 2021 Mar 4;33(2):121-132. doi: 10.1515/jbcpp-2020-0279.
5
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.假定多巴胺激动剂(KB220Z)可减轻创伤后应激障碍患者的清醒梦:增强的脑奖赏功能连接和内稳态恢复性愉悦的作用。
J Behav Addict. 2015 Jun;4(2):106-15. doi: 10.1556/2006.4.2015.008.
6
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.内源性大麻素系统调节意识水平、情绪及可能的梦境内容。
CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908.
7
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.大麻素与创伤后应激障碍:治疗与预防的临床及临床前证据
Behav Pharmacol. 2016 Oct;27(7):561-9. doi: 10.1097/FBP.0000000000000253.
8
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.合成大麻素那必隆治疗创伤后应激障碍相关噩梦的疗效:一项初步随机双盲安慰剂对照交叉设计研究
Psychoneuroendocrinology. 2015 Jan;51:585-8. doi: 10.1016/j.psyneuen.2014.11.002. Epub 2014 Nov 8.
9
Sleep and Dreaming in Posttraumatic Stress Disorder.创伤后应激障碍中的睡眠与梦境
Curr Psychiatry Rep. 2017 Aug 22;19(10):71. doi: 10.1007/s11920-017-0827-1.
10
An Ambulatory Polysomnography Study of the Post-traumatic Nightmares of Post-traumatic Stress Disorder.创伤后应激障碍创伤后夜间梦魇的动态多导睡眠描记术研究。
Sleep. 2018 Jan 1;41(1). doi: 10.1093/sleep/zsx188.

本文引用的文献

1
Publisher Correction: Mechanisms of systems memory consolidation during sleep.出版商更正:睡眠期间系统记忆巩固的机制。
Nat Neurosci. 2019 Oct;22(10):1743-1744. doi: 10.1038/s41593-019-0507-z.
2
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.大麻素治疗创伤后应激障碍(PTSD)的疗效:系统评价。
J Dual Diagn. 2020 Jan-Mar;16(1):120-139. doi: 10.1080/15504263.2019.1652380. Epub 2019 Sep 3.
3
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
医用大麻和合成大麻素在创伤后应激障碍(PTSD)中的应用:系统评价。
Medicina (Kaunas). 2019 Aug 23;55(9):525. doi: 10.3390/medicina55090525.
4
Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms.创伤后应激障碍及其他焦虑相关障碍中的睡眠障碍:临床特征、生理特征及心理和神经生物学机制的最新综述。
Neuropsychopharmacology. 2020 Jan;45(1):55-73. doi: 10.1038/s41386-019-0486-5. Epub 2019 Aug 23.
5
Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans.Δ9-四氢大麻酚对人类威胁性消退记忆长期神经相关物的影响。
Neuropsychopharmacology. 2019 Sep;44(10):1769-1777. doi: 10.1038/s41386-019-0416-6. Epub 2019 May 16.
6
Structural Insights into CB1 Receptor Biased Signaling.结构洞察大麻素 CB1 受体偏向信号传导。
Int J Mol Sci. 2019 Apr 13;20(8):1837. doi: 10.3390/ijms20081837.
7
Cannabinoid interventions for PTSD: Where to next?大麻素干预 PTSD:下一步在哪里?
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:124-140. doi: 10.1016/j.pnpbp.2019.03.017. Epub 2019 Apr 1.
8
Glucocorticoid-induced enhancement of extinction-from animal models to clinical trials.糖皮质激素诱导的消退增强:从动物模型到临床试验。
Psychopharmacology (Berl). 2019 Jan;236(1):183-199. doi: 10.1007/s00213-018-5116-0. Epub 2019 Jan 4.
9
Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies.用大麻素缓和痛苦/创伤记忆:来自动物和人类研究的证据综述。
Psychopharmacology (Berl). 2019 Jan;236(1):201-226. doi: 10.1007/s00213-018-5127-x. Epub 2019 Jan 2.
10
Cortico-limbic pain mechanisms.皮质-边缘疼痛机制。
Neurosci Lett. 2019 May 29;702:15-23. doi: 10.1016/j.neulet.2018.11.037. Epub 2018 Nov 29.